THE Competition and Consumer Protection Commission (CCPC) has directed the Football Association of Zambia (FAZ) and MTN Zambia to allow City of Lusaka Football Club to use the Woodlands Stadium while the commission is still concluding its instituted investigations in the case involving the named parties.
The commission has further allowed Woodlands Stadium to be used for other football fixtures such as cup tournaments with immediate effect.
This follows the August 24th allegations filed at the commission alleging that FAZ and MTN had issued a letter to City of Lusaka F.C. which prohibited the use of Woodlands stadium for any Super League matches due to the presence of Vodafone Zambia (Vodafone) paraphernalia and branding within the stadium.
But in a statement issued by CCPC Public Relations Officer Namukolo Kasumpa, the commission has allowed City of Lusaka Football Club to continue using the stadium until the ongoing investigations are concluded.
“The decision to place interim measures allowing the use of the stadium was made by the Technical Committee of the Board on 20th October 2017 in Lusaka. This interim measure undertaken by the Commission is provided for under section 62 of the Competition and Consumer Protection Act no. 24 of 2010. This section allows the Commission to offer relief to a party of an ongoing investigation of an alleged anti-competitive conduct,” Kasumpa said.
Kasumpa also revealed that FAZ has further advised City of Lusaka F.C. to find an alternative venue for their remaining home fixtures for the season as the branding by Vodafone was allegedly in violation of the sponsorship agreement between FAZ and MTN.
“The Commission instituted investigations and wrote to FAZ and MTN on the above allegations on 6th September 2017, and to-date has not received any response from FAZ, while MTN responded stating that they did not make the decision to stop Vodafone from branding the stadium and evicting the club from the stadium as the decision was entirely made by FAZ,” Kasumpa said.
“Investigations thus far have revealed that City of Lusaka and other sponsors have from the 24th of August 2017 to the 4th of October 2017 incurred an estimated total loss of three million seven hundred and thirteen kwacha (K3,713,000) and are likely to lose sponsorship if the status core continues.”
She said the the Technical Committee of Board put in place interim measures allowing the use of the stadium with immediate effect, until such time as full investigations were completed by the Commission.
And Kasumpa said the Commission will continue to get necessary information regarding this matter to enable a thorough investigation and the Media will continue to be updated on the findings and course of action.
Vehicles in Zambia increased to 853,909, RTSA, Police say
Zambia allocated 8.7 million doses of COVID-19 vaccines
ZAMBIA has been allocated 8.7million doses of Covid-19 vaccines under a facility being pioneered by the Africa Union.
Zambia’s Ambassador to Ethiopia and Permanent Representative to the African Union, His Excellency Emmanuel Mwamba announced the development.
He said the initiative is being done under the COVID-19 African Vaccine Acquisition Task Team (AVATT) a platform which has been created to ensure that upto 60% of Africa’s population were vaccinated against the Coronavirus by December 2021.
He said AVATT was created by President Cyril Ramaphosa, Chairperson of the African Union, in November 2020.
He said AVATT has been mandated to secure the necessary vaccines and blended financing resources for achieving Africa’s COVID-19 vaccination strategy which targets vaccinating a minimum of 60 per cent of Africa’s population.
Mr. Mwamba said AVATT’s efforts are focused on; securing enough safe and efficacious vaccine doses to vaccinate at least 60 per cent of the African population, estimating the funding needs for vaccine procurement and delivery and creating the financing mechanisms required to ensure that all African Union Member States can access and receive the vaccine doses they need to reach a minimum of 60 per cent immunisation.
He said under the mechanism, the vaccines are being sourced from Pfizer, Johnson and Johnson, and AstraZeneca.
Pfizer and Johnsons &Johnsons are among the world’s largest pharmaceutical companies, while AstraZeneca PLC is a British-Swedish multinational pharmaceutical.
He said a finance facility has been created under the AVATT- the Advance Procurement Commitment (APC) Facility to be backed by African Import and Export Bank (Afreximbank).
He said this mechanism aims at ensuring Africa’s access to the COVID-19 vaccines from no later than April 2021, by providing assurance to identified vaccine manufacturers that vaccine orders placed through the African Medical Supplies Platform (AMSP), are firm and will be paid for as may be agreed.
APC aims to guarantee Africa’s access to of COVID-19 vaccines in a manner that reduces the fiscal burden on member countries.
The mechanism will also ensure a timely, equitable and cost-effective availability of COVID-19 vaccine supplies within the African continent and by so doing, mitigate the protracted financial and socio-economic costs of the COVID-19.
This is also to provide a credible platform around which a blend of funding can be attached to
support Africa’s COVID-19 vaccine procurement requirements.
The Task Team has provisionally secured 270 million vaccine doses for Africa for the critical period from April to December 2021.
He said Zambia’s allocation may rise to 25million doses by December 2021.
These vaccine doses, which are in addition to the expected COVAX doses, will be distributed through the African Medical Supplies Platform (AMSP).
The candidates and related quantities are; 50 million doses of the Pfizer/BioNTech vaccine, 100million doses of the AstraZeneca vaccine, through the Serum Institute of India and 120 million doses of the Johnson and Johnson vaccine (upon satisfactory conclusion of phase III trials).
He said the vaccines will obtain prior approval by AVATT on the recommendation of the Africa-CDC.
Africa CDC will approve the vaccines having considered the necessary conditions, efficacy including vaccines which have been trialed in Africa and safety.
Mr. Mwamba said the Permanent Representative Committee (PRC) was briefed of the progress that has been made to ensure that member states began to receive the vaccines from March- April 2021.
This is according to issued by Mrs. Inutu Mupango Mwanza First Secretary (Press&Tourism), Addis Ababa,Ethiopia